TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

about

Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.

P2860

Q47140849-92E3471B-84A7-495D-837B-4E42CBBB0386

P2860

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

Item

http://www.wikidata.org/entity/Q43605106

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@en

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@nl

type

Item

label

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@en

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@nl

prefLabel

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@en

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@nl

P1476

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

@en

P2093

Baorui Liu

http://www.w3.org/2001/XMLSchema#string

Jia Wei

http://www.w3.org/2001/XMLSchema#string

Jie Shen

http://www.w3.org/2001/XMLSchema#string

Jing Hu

http://www.w3.org/2001/XMLSchema#string

Li Xie

http://www.w3.org/2001/XMLSchema#string

Lixia Yu

http://www.w3.org/2001/XMLSchema#string

Qun Zhang

http://www.w3.org/2001/XMLSchema#string

Wenxian Guan

http://www.w3.org/2001/XMLSchema#string

Xiaoping Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.

Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer.

Analyzing real-time PCR data by the comparative C(T) method

Data acquisition for the histoculture drug response assay in lung cancer.

Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.

Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications.

Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.

P2888

s00280-013-2354-z

P304

325-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-013-2354-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hao Wang

P577

2013-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049253450

http://www.w3.org/2001/XMLSchema#string

P698

24281197

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

about

P2860

P2860

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921